A research group at the RIKEN Center for Biosystems Dynamics Research (BDR) has discovered molecular events that determine whether cancer cells live or die. With this knowledge, they found that reduced consumption of a specific protein building block prevents the growth of cells ...Learn More

CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats), a revolutionary gene-editing tool which has the ability to edit nearly any segment of DNA with more precise than any other DNA-editing tools. This DNA editing tool is highly used in the cancer research field in ...Learn More

EXPERT aims at developing a new off-the-shelf delivery system for RNA-based nanomedicines to treat cancer and cardiovascular disease. In the long term, the platform technology could be used for improving diagnostic and therapeutic options for patients with several other diseases. ...Learn More

Fusion oncogenes are strong driven factor for tumor progress, which only express in cancer cell. Researchers observed that eliminating directionally fusion oncogenes where the cancer induced by that, giving rise to apoptosis of cancer cells. Though this therapeutic target is very ...Learn More

Cancer is curable